论文部分内容阅读
前瞻性研究晚期前列腺癌患者接受己烯雌酚加小剂量新双香豆素治疗的安全性和有效性。自１９９４年２月～１９９６年４月对３２例晚期前列腺癌患者进行观察。年龄４２～８９岁，中位数７４岁。分两组，一组每天接受新双香豆素１ｍｇ，己烯雌酚３ｍｇ（年龄＜６５岁）；另一...
Prospective study of advanced prostate cancer patients receiving diethylstilbestrol plus a small dose of new dicoumarol treatment of safety and efficacy. From February 1994 to April 1996 32 patients with advanced prostate cancer were observed. Age 42 ~ 89 years old, the median 74 years old. Divided into two groups, one group received daily new dicoumarin 1mg, diethylstilbestrol 3mg (age <65 years); the other ...